About [6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone
[6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone (PubChem CID 168987901) has the molecular formula C18H15BrF2N4O
and a molecular weight of 421.25 g/mol. Its IUPAC name is [6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone.
Analyze [6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone?
The IUPAC name of [6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone (CID 168987901) is [6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone.
What is the SMILES notation for [6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone?
The canonical SMILES for [6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone is O=C(c1ccc(-n2ncc3cc(Br)ccc32)nc1)N1CCC(F)(F)CC1.
What is the InChIKey of [6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone?
The InChIKey is UQZSHXANRDTQNG-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H15BrF2N4O/c19-14-2-3-15-13(9-14)11-23-25(15)16-4-1-12(10-22-16)17(26)24-7-5-18(20,21)6-8-24/h1-4,9-11H,5-8H2.
What are the key properties of [6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone?
[6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone has a molecular weight of 421.25 g/mol, XLogP of 4.05, 2 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [6-(5-bromoindazol-1-yl)-3-pyridinyl]-(4,4-difluoropiperidin-1-yl)methanone is sourced from PubChem (CID 168987901), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).